Becton, Dickinson Q4 2026 Earnings Preview
Seeking Alpha News (Wed, 5-Aug 11:43 AM ET)
TipRanks (Wed, 5-Aug 2:56 AM ET)
Intuit, Alphabet, Honeywell, BDX, Stryker Trending With Analysts
TipRanks (Sat, 1-Aug 5:01 AM ET)
EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch
PRNewswire (Wed, 29-Jul 6:56 AM ET)
PRNewswire (Tue, 28-Jul 4:15 PM ET)
Mike Garrison to Retire from BD
PRNewswire (Wed, 22-Jul 6:55 AM ET)
BD to Announce Financial Results for its Third Quarter of Fiscal 2026
PRNewswire (Thu, 9-Jul 4:15 PM ET)
BD Awarded Vizient Innovative Technology Contract for CentroVena One Insertion System
PRNewswire (Tue, 23-Jun 6:50 AM ET)
BD Delivers Kidney Stone Care for Urology Teams with the Elyra Thulium Fiber Laser System
PRNewswire (Thu, 21-May 6:50 AM ET)
Peter Menziuso Named EVP and President, BD Interventional
PRNewswire (Mon, 18-May 6:50 AM ET)
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
Becton Dickinson And Company trades on the NYSE stock market under the symbol BDX.
As of August 5, 2026, BDX stock price climbed to $170.66 with 2,144,469 million shares trading.
BDX has a beta of 0.34, meaning it tends to be less sensitive to market movements. BDX has a correlation of 0.03 to the broad based SPY ETF.
BDX has a market cap of $48.55 billion. This is considered a Large Cap stock.
Last quarter Becton Dickinson And Company reported $5 billion in Revenue and $2.90 earnings per share. This beat revenue expectation by $43 million and exceeded earnings estimates by $.13.
In the last 3 years, BDX traded as high as $284.48 and as low as $140.11.
The top ETF exchange traded funds that BDX belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
BDX has underperformed the market in the last year with a return of +22.6%, while SPY returned +23.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in BDX shares. However, BDX has outperformed the market in the last 3 month and 2 week periods, returning +17.4% and +10.9%, while SPY returned +7.5% and +2.9%, respectively. This indicates BDX has been having a stronger performance recently.
BDX support price is $166.91 and resistance is $173.33 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BDX shares will trade within this expected range on the day.